Does RISANKIZUMAB-RZAA Cause Joint dislocation? 69 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 69 reports of Joint dislocation have been filed in association with RISANKIZUMAB-RZAA. This represents 0.1% of all adverse event reports for RISANKIZUMAB-RZAA.
69
Reports of Joint dislocation with RISANKIZUMAB-RZAA
0.1%
of all RISANKIZUMAB-RZAA reports
0
Deaths
29
Hospitalizations
How Dangerous Is Joint dislocation From RISANKIZUMAB-RZAA?
Of the 69 reports, 29 (42.0%) required hospitalization.
Is Joint dislocation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 69 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Joint dislocation?
ADALIMUMAB (1,549)
ETANERCEPT (802)
METHOTREXATE (792)
TOFACITINIB (685)
ABATACEPT (656)
TOCILIZUMAB (646)
CERTOLIZUMAB PEGOL (577)
GOLIMUMAB (572)
RITUXIMAB (557)
DICLOFENAC (536)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Joint dislocation Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA